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Coronary artery disease is the leading cause of death 
worldwide. Its first and only symptom may be fatal acute 
myocardial infarction. Early detection offers the greatest chance of 
slowing or even abating the disease process before it progresses. 
Infact early diagnosis is critical in saving precious lives. 
Prognosticative management based on various parameters of 
ECG have been proposed. Some of the proposed techniques include  
T wave alternans, heart rate variability, QTc interval and QTc 
dispersion. Of these QTc dispersion which is defined as the 
difference between the longest and  the shortest QTc interval is 
undergoing rigorous assessment. 
Over the past ten years quite a few studies have been 
published evaluating QTc dispersion as a predictor of arrhythmias 
and sudden cardiac death. Indian studies for the same are very few. 
Hence a study of QTc dispersion in acute myocardial infarction 
stratifying the population into various subgroups and type of 
infarct was planned. A control group was also taken to find the 
normality of QTc dispersion values. The study also looked into the 
effect of drugs, thrombolysis on QTc dispersion. Finally the study 
considered the effect of QTc dispersion on mortality with regard to 
its prognostic and preventive implication. 
AIMS AND OBJECTIVES 
To assess the degree of QTc dispersion in patients getting 
admitted to Intensive Coronary  Care Unit of Government 
Royapettah Hospital / Kilpauk Medical College, Chennai with acute 
myocardial infarction at the time of admission, post thrombolysis 
and one day after admission. 
To study and compare QTc dispersion patterns in various 
types of myocardial infarction. 
To find out whether any association exist between variables 
such as age, sex, diabetes, hypertension, smoking and QTc 
dispersion. 
To study association between QTc dispersion and cardiac 
arrhythmias, left ventricular failure and death during the first 
twenty four hours after acute myocardial infarction. 
To find out the normal range of QTc dispersion in the 






















































REVIEW OF LITERATURE 
 Attempts to characterize the abnormalities of ventricular 
repolarization from the surface electrocardiogram (ECG) have a 
long history. Precise mathematical approaches can be traced back 
to the 1960s (1). For clinical purposes, however, the ECG based 
assessment of ventricular repolarization has traditionally been 
limited to the measurement of the QTc interval and to the 
description of the polarity and shape of the T wave often using 
vague terms such as “nonspecific ST segment and T wave 
changes.”```` 
 In 1990, a report by the group led by the late Professor 
Campbell revived an old idea of the interlead differences in the QTc 
interval duration. The range of the durations termed “QTc 
dispersion" was proposed as an index of the spatial dispersion of 
the ventricular recovery times (2). It was proposed that the 
different myocardial regions had  different ECG signals and hence, 
QTc dispersion is an almost direct measure of the heterogeneity of 
myocardial repolarization. The cardiological community welcomed 
the idea. The methodological simplicity and the promise of solving 
the old and much debated problem of regional information within 
the standard ECG were appealing. 
 Since the first publication, the cardiological literature has 
been flooded by articles reporting QT dispersion in practically every 
cardiac as well as many noncardiac syndromes and diseases. 
However, voices of concern about the validity of the concept and the 
methodology of the measurement were raised repeatedly. Today, 
after a decade of the “QT dispersion era,” some conclusions may be 
drawn from the wide spectrum of opinions (3). 
Pathophysiology of QTc dispersion 
 The initial concept of QTc dispersion seemed to be based on a 
sound logic. The link between the dispersion of ventricular recovery 
times and arrhythmias had been demonstrated repeatedly (4, 5, 6). 
It was also believed that the standard surface ECG contains 
regional information. Therefore, finding increased QTc dispersion 
in patient groups in whom the heterogeneity of the ventricular 
recovery times was previously established, it was assumed that 
QTc dispersion is a reflection of the dispersion of ventricular 
recovery times. The validity of the concept seemed to be further 
consolidated by studies correlating intracardiac monophasic action 
potentials (MAPs) with various QTc dispersion indices. 
 Higham et al. (7) recorded epicardial MAPs during cardiac 
surgery and measured directly the dispersion of recovery times as 
well as surface QTc dispersion during sinus rhythm and during 
ventricular pacing. They found a high positive correlation between 
the MAPs and ECG dispersion indices. Later, using a custom-built 
rabbit heart setup with simultaneous recording of MAP and 12-lead 
ECGs, Zabel et al. (8) showed that the dispersions of the QT and JT 
intervals were significantly correlated with the dispersion of 90% 
duration of the action potential duration (APD90) and with the 
dispersion of recovery times. The same authors also confirmed this 
in patients with 12-lead ECGs recorded within 24 h of the MAPs (9). 
These studies were generally interpreted as a proof of QTc 
dispersion representing regional variations in the duration of the 
ventricular action potentials. 
 Serious arguments against this concept originated from the 
electrocardiographic lead theory. If the majority of the information 
about the ventricular electrical activity is contained in the spatial 
QRS and T loops, the major reason for the difference between 
separate leads has to be the loss of information from the projection 
of the loop into the separate leads (10). Macfarlane et al. (11) and 
Lee et al. (12) showed independently that QTc dispersion can also 
be found in the so called derived 12-lead ECGs, i.e., ECGs 
reconstructed from the XYZ leads, which naturally contain no 
regional information. 
 Kors et al.(13) further contributed to the understanding of 
the interlead differences. They found that QTc dispersion was 
significantly different between patients with narrow (54.2 ± 27.1 
ms) and wide T loops (69.5 ± 33.5 ms, P <0.001). They also showed 
that in each of the six limb as well as the six precordial leads, the 
difference between the QTc interval in a given lead and the 
maximum QTc interval was dependent on the angle between the 
axis of the lead and the axis of the terminal part of the T loop. 
 Punske et al. (14) compared the spatial distribution of the 
QTc intervals from high resolution maps on human body surface. 
These studies showed convincingly that the interlead differences of 
the QTc intervals are a reflection of   morphology of the T wave loop 
and could be quantified . 
Most recently, Malik et. al. (15) proposed a new ECG 
processing technique to distinguish the T wave signals representing 
the three  dimensional movement of the ECG dipole from the 
nondipolar components likely to be related to regional 
heterogeneity of myocardial repolarization.  
Hence, it is reasonable to conclude that the dispersions of 
ventricular recovery times measured with MAPs and QTc 
dispersion are direct and indirect expressions of repolarization 
abnormalities that are likely to correlate even without any 
mechanistic link. General abnormalities of ventricular 
repolarization, not only those leading to regional dispersion of 
recovery times modify the spatial T wave loop. As a result of any 
abnormality, projections of the loop into the individual ECG 
tracings become more difficult to be localized. The effect of local 
dispersion of repolarization on the morphology of the T wave loop 
explains the (indirect) link between MAP recordings and QTc 
dispersion. Thus, T wave loop dynamics and the variable 
projections of the loop into individual ECG leads seem to be the 
true mechanistic background of QTc dispersion.  
 The studies of the link between the T loop morphology and 
QTc dispersion also confirmed what was empirically known long 
ago : the more abnormal the T wave morphology in separate leads, 
the more difficult and unreliable the localization of the T wave 
offset in each lead and, consequently, the greater the likelihood of 
an increased QTc dispersion. As Kors et al. (13) demonstrated, 
variations of the T loop morphology lead to variations in the 
practically unmeasurable final part of the T wave, i.e., the 
proportion of the signal falling within the noise bang. Thus, 
variations of the T loop morphology may lead to both true 
variations in the length of the projections of the T loop onto the 
separate leads and to an increased measurement error. 
Projections of T loops with different shapes and at different 
angles to the axis of the lead result in T waves with different 
amplitude and morphology. Only an insignificant proportion of the 
final part of a T wave with high amplitude may be unmeasurable 
because of falling into the noise band. T waves with smaller 
amplitude as a result of wider T loop or elongated loop at different 
angle have a greater proportion of their final parts falling into the 
noise band. Thus, the measurable QT interval can almost coincide 
with the real end of repolarization or be significantly smaller (13).  
QTc dispersion is a result of both difference in real duration 
and  measurable  duration of QTc intervals. Two hypothetical T 
waves of the same amplitude have different offset when the heart 
vector becomes perpendicular to the axis of one of the leads. This 
results in “real” dispersion of the QTc intervals. In addition, 
different proportion of the final part of the two T waves is below the 
threshold level (e.g. with an automatic threshold method). This 
leads to the measured dispersion of the QTc intervals, which is 
different from the real dispersion. 
It is now clear that QTc dispersion is merely a crude and 
indirect measure of general repolarization abnormalities. At the 
same time, disproving this hypothesis is not a good reason for 
stating that “QTc dispersion does not exist.” QTc dispersion is 
clearly only a very approximate and rather simplistic expression of 
repolarization abnormalities that suffers from a poor 
pathophysiologic concept as well as, from methodological difficulties. 
However, regardless of the crudeness of the expression, 
abnormalities of the repolarization are of significant importance (16,  
17). Even very indirect and very approximate measure of T wave 
loop abnormalities may still have some, though restricted, 
informative value. 
Measurement of QTc dispersion 
 It has been known for decades that manual determination of 
the T wave offset is very unreliable (18). Unfortunately, available 
automatic methods have not proven their superiority. The main 
sources of error, both for human observes and computers, are low T 
wave amplitude (19, 20) and merges of T waves with U and / or P 
waves. The morphology of the T wave also strongly influences QT 
interval measurement. 
 Several basic algorithms for automatic determination of the T 
wave end are available. The threshold methods localize the T offset 
as an intercept of the T wave or of its derivative with a threshold 
above the isoelectric line, usually expressed as a percentage of the 
T wave amplitude. The slope methods determine the T offset as an 
intercept between the slope of the descending part of the T wave 
and the isoelectric line, or a threshold line above it. The slope can 
be the steepest tangent computed by various line fitting algorithms 
or a straight line through the inflex point and the peak of the T 
wave. Obviously, the measured values of the QT interval depend on 
the shape of the descending part of the T wave. The amplitude of 
the T wave strongly influences the reliability of both automatic (19 
and 21) and manual (20) measurement. 
U wave 
 The origin of the U wave remains disputed. The theories that 
attributed the U wave to the delayed repolarization of the His-
Purkinje fibre (22) or to mechanoelectrical mechanism (23), were 
superseded by the M-cell theory by Antzelevich et al (24). However, 
later experiments by the same group showed that what is often 
interpreted as a “Pathologically augmented U wave” or “T-U 
complex” is in fact a prolonged biphasic T wave with an interrupted 
ascending or descending limb (25). Manual measurement is even 
less reliable for certain T-U patterns, e.g. when the T wave is flat or 
inverted and the U wave augumented. Repolarization pattern of 
complex morphology are frequently classified differently by 
different observes, leading to substantial variability of the 
measurement (26). 
 Probably, electrophysiological mechanisms responsible for 
usual “physiologic” U wave are different from those leading to 
abnormal gross U waves, for instance those seen in congenital and 
acquired long QT syndrome. All repolarization signal originating 
from repolarization of ventricular myocardium should belong to the 
T wave. In this sense, the concept of biphasic and other unusually 
shaped T waves is more appropriate than a distinction between the 
T wave and an augmented U wave which may lead to serious 
underestimation of QTc interval. 
 A pattern resembling a U wave may also originate from slow 
afterdepolarization of ventricular myocytes. Distinction of such a 
pattern from bizarre T wave may be very difficult. At the same time, 
in practical QTc interval measurement signs of after 
depolarizations indicate the same proarrhythmic danger as bizarre 
T wave shapes and prolonged QT interval. 
 Thus, in all cases that are difficult to reconcile, augmented U 
waves should be preferably included into the T wave. Only 
distinction between T wave and clearly physiologic U waves of 
small amplitude should be attempted when measuring QTc interval. 
 Already in 1952, Lepeschkin and Surawicz (27) described and 
classified various patterns of T and U wave merging and suggested 
methods for determining the end of the T wave when “buried” 
within the U wave. They showed that, depending on the pattern of 
T-U wave merging, either the intersection of the tangent to the 
downslope steepest point with the isoelectric line, or the nadir 
between the T and the U wave is closer to the “real” T wave end. 
The tangent method was proposed merely as “… an attempt to 
determine the true end of the T wave in cases of partial merging of 
T and U …” (27), rather than as a universal method for 
determining of the end of the T wave. 
 In a recently published extensive review, Surawicz (28) 
summarized the available knowledge that could help distinguish 
normal or abnormal U wave merging with a T wave. 
JT dispersion 
 In experimental and clinical studies, Zabel et al. (8, 9) showed 
that the QTc dispersion value reflect better the dispersion of the 
recovery times than the action potential duration. On the other 
hand, the JT dispersion reflected better the dispersion of action 
potential duration (APD90). Consequently, some authors suggested 
the QTc and JT dispersions to be used as separate entities rather 
than mutual surrogates (19, 30). However, neither the QTc 
dispersion nor the JT dispersion reflect directly the dispersion of 
the ventricular recovery time or of the action potential duration. 
The dispersion of various repolarization duration intervals is 
merely an indirect measure of general repolariztion abnormalities. 
It is therefore questionable whether JT dispersion offers any real 
complement to the QTc dispersion, except possibly in cases of 
conduction abnormalities such as bundle branch block. 
 The Q wave dispersion, although significantly smaller than 
the T wave offset dispersion, may also influence QTc dispersion (31, 
32). Traditional manual measurement, as well as some computer 
algorithms, assesses the Q wave onset separately in each lead (33), 
whereas other computer algorithms use a common, lead-
independent Q onset (34, 35). This may account for part of the 
variability between different algorithms. 
Measurement Features 
 Theoretically, an accurate assessment of QTc dispersion 
requires all 12 lead of the ECG to be recorded simultaneously in 
order to avoid the effect of QT dynamicity due to heart rate changes. 
Therefore, simultaneous 12  lead recordings have been proposed as 
a “gold standard” for QTc dispersion measurement. On the other 
hand, it is possible that the slow dynamicity of the QT interval (36) 
renders QTc dispersion measurement based on simultaneous 
recording of six or even only three recording during ectopic  free 
sinus rhythm acceptable for practical purposes. 
Influence of heart rate 
 Many studies, including large prospective evaluations (37, 38) 
used the so-called corrected QTc dispersion, i.e., the dispersion of 
the QT intervals corrected for heart rate by some formula. 
Although the applications of additive formulae for heart-rate 
correction such as those proposed by Hodgets et al. (39) and in the 
Framingham Study (40) render identical values for QT dispersion 
and QTc dispersion. 
 Although experimental and clinical data show that the rate, 
the rhythmicity and the site of impulse origin can influence the 
dispersion of the ventricular recovery time (41, 42, 43), this has 
never been shown for QTc dispersion. Clinical (44) and 
experimental (45) studies failed to find correlation between heart 
rate and the dispersion of ventricular recovery times measured 
with MAPs or QT dispersion. 
 The exact relation between the heart rate and the dispersion 
of recovery times is still and unresolved issue. It is certain, however, 
that QTc dispersion measured in the standard 12-lead ECG does 
not depend on the heart rate in the same way as the QTc interval 
(46).  
Influence of the number of ECG leads and of the ECG lead 
system 
 The number of measurable leads in the standard ECG also 
influences the range of QTc interval durations. Some researchers 
proposed a correction factor dividing QTc interval range by the 
square root of the number of measurable ECG leads, leading to the 
so called adjusted QTc dispersion (50). Hnatkova et al. (47) showed 
that this formula results in a reasonable correction of mean values 
of QTc dispersion in normal ECGs. However, they also showed that 
the individual errors caused by omitting separate leads are very 
substantial. Consequently, it is not appropriate to compare results 
based on QTc interval values measured in ECGs of very different 
number of measurable leads. 
 Many clinical studies have measured QTc dispersion only in 
the six precordial leads. In addition, other lead combinations, such 
as the orthogonal XYZ or “quasiothogonal” I, aVF or V2 leads, have 
also been studied. It was reported that although, as one would 
expect, QTc dispersion is decreased when a smaller number of leads 
used for QTc measurement. QTc dispersion differences between 
different patient groups can still be detected with the three leads 
(aVF, V1, V4) that are most likely to contribute to QTc dispersion 
(51) : the limb leads (52), the orthogonal (X,Y,Z) (53 and 54) or the 
quasiorthogonal leads aVF and V2 (51 52 and 53). Clearly, 
practically any lead combination may detect abnormalities in the 
morphology of the T loop and translate them into increased values 
of QTc dispersion. On the other hand, the more projections of the T 
loop into different leads with different axes are used, the more 
sensitive the measurement becomes. Unfortunately, as already 
mentioned, none of this directly translates into an increased 
regional heterogeneity of recovery times. Therefore there is little 
point in continuing the quest for the “perfect lead combination” for 
QTc dispersion measurement. 
Reliability of QTc dispersion assessment 
 Many studies have shown inter and intraobserver variability 
of manually measured QTc dispersion. The errors reach the order of 
the differences between normal subject and cardiac patients. 
Relative errors of 25-40% of interobserver and intraobserver 
variability of manual measurement of QTc dispersion have been 
reported (27 and 55), and opposed to relative errors <6% for manual 
measurement of the QTc interval (55). Occasionally, substantially 
better reproducibility of manual measurement of QTc dispersion 
has also been reported, with interobserver variability of 13-18% (56) 
and even 5% (57). Explanations of these discrepancies can only be 
very speculative. Because a majority consensus clearly agrees on 
poor reproducibility of QTc dispersion measurement a wishful bias 
was likely involved in some reports presenting very low 
measurement errors. 
 In addition to the differences in the investigated population, 
the variations of the results can be attributed to differences in the 
measurement method (manual measurement with caliper or rule) 
(58), application of a digitizing board with or without 
magnifications, on screen measurement with electronic calipers, 
the noise level, and the paper speed at which the ECGs were 
recorded (20). In a technical study, Malik and Bradford (59) showed 
that even the “gold standard” manual measurement using the 
digitizing board, can produce intraobserver variations 
corresponding to purely error-related QTc dispersion >40 ms and 
>60 ms  in 20% and 10% of observers, respectively. 
 The available automatic methods for QT measurement have 
not shown a superior reproducibility. For example, Yi et al. (60) 
reported that the immediate reproducibility (in sequentially 
recorded ECGs) of various QTc dispersion indices measured with a 
downslope tangent method in healthy volunteers varied between 
16% and 44%. 
 Many studies tried to validate automatic algorithms against 
manual measurement by experienced ECG readers. The results 
were disappointing showing large difference (21, 62, 63 and 64). 
Savelieva et al. (63) investigated the agreement between automatic 
(downslope tangent) and manual QTc measurement in normal 
subjects and patients with HCM. The agreement between the two 
methods of QTc interval measurement was poor and lower in 
normal subjects than in HCM patients. The agreement between 
automatic and manual measurement of QTc dispersion was even 
much worse. 
Clinical studies 
 A review of the extreme abundance of studies on QTc 
dispersion published over the past decade reveals an amazingly 
wide range of QTc dispersion values in both “positive” and 
“negative” studies, and a complete lack of any tendency towards 
establishing reference values. For example, large studies (67) or 
literature reviews (68) suggesting QTc dispersion of 65 ms as an 
upper normal limit in healthy subjects were published alongside 
reports claiming QTc dispersion >40 ms to have 88% sensitivity 
and 57% specificity for prediction of inducibility of sustained 
ventricular tachycardia during and electrophysiology study (69). 
QTc dispersion in normal subjects and in the general 
population 
 Literature reviews found the QTc dispersion to vary mostly 
between 30 and 60 ms in normal subject (70 and 71), although 
average values around 70 ms were also reported. In 51 studies (40 
published during the past three years) in which QTc dispersion was 
measure in 56 subgroups with a total of 8,455 healthy subjects of 
various ages (including three large studies of healthy children (72, 
73 and 74), found mean QTc dispersion values (QT maximum-QT 
minimum) to range from 10.5 ± 10.0 ms (75) to 71 ± 7 ms (76). The 
weighted mean ± SD from all these studies is 33.4 ± 20.3 ms while 
the median in 37 ms. Moreover, most researchers reported a wide 
overlap of values between normal individuals and different patient 
groups.. 
 Published reports show either no statistically significant 
difference in QTc dispersion between the genders (11, 73) or 
marginally greater values in men (77, 78). Age related differences 
less of  than 10 ms were reported and appeared to be statistically 
significant in some studies (79, 80) but not in others (72, 73). For 
example, in the study by Savelieva et al. (81) on more than 1,000 
healthy subjects, QTc dispersion was 29.1 ± 17.8 ms in the age 
group of 17 to 29 years and 21.7 ± 13.3 ms in the age group of 50 to 
80 years (P<0.0001). However, in another large study, Macfarlane 
et al. (11) found no significant age differences (QTc dispersion of 
23.6 ± 7.7 ms, 24.8 ± 8.2 ms, 24.8 ± 8.5 ms and 24.5 ± 9.8 ms in the 
age group of < 30, 30-40, 40-50 and >50 years  respectively). In this 
study, no age differences of QTc dispersion were found in 1,784 
neonates, infants and children divided in 16 age group from >24 h 
to <15 years of age. 
 Several large prospective studies published recently assessed 
the predictive value of QTc dispersion for cardiac and all-cause 
mortality in the general population. In the Rotterdam study (37) 
QTc dispersion was found to predict cardiac mortality in a general 
population of 5,812 adults of 55 years or older, followed up for 3 to 
6.5 years. 
 In the Strong Heart Study (38) the predictive value of the 
“corrected” QTc dispersion was assessed in 1,839 American Indians 
followed up for 3.7 ± 0.9 years. Heart rate corrected QT interval 
assessed as a continuous variable remained a significant and 
independent predictor of cardiovascular mortality in both 
univariate and multivariate Cox Proportional Hazard models, with 
34% increase of cardiovascular mortality for each 17 ms increase in 
QTc dispersion in multivariate analysis. In multivariate analysis 
QTc dispersion >58 ms (the upper 95th percentile in a separate 
population of normal subjects) was associated with a 3.2 – fold 
increased risk of cardiovascular mortality (95% confidence interval 
(CI) 1.8-5.7). Unfortunately, no values for the uncorrected QTc 
dispersion or the simple resting heart rate were provided. Thus, the 
possibility of the strong predictive power being maintained by the 
differences in heart rate cannot be excluded. 
 The West of Scotland Coronary Prevention Study (WOSCOPS) 
(82) included 6,595 middle-aged men with moderately raised 
cholesterol but no previous MI. In a multivariate analysis, and 
increment of 10 ms in QTc dispersion increased risk for death of 
coronary heart disease or nonfatal MI by 13% (95% CI 14% to 22%, 
p = 0.0041). QTc dispersion >44 ms carried an increased risk of 36% 
(95% CI 2% to 81%, p = 0.034) compared with QTc dispersion <44 
ms. On the other hand, this cutoff level of 44 ms had a sensitivity of 
only 8.8% with a specificity of 93.8%. The area under the receiver 
operator characteristic curve was only 54%. Indicating an almost 
complete  lack of predictive  power  of  QTc dispersion. 
QTc dispersion in cardiac disease 
 There is a clear tendency towards increase of QTc dispersion 
in various cardiac diseases, with highest mean values reported in 
long  QT syndrome, “the pure global repolarization disease”. On the 
other hand the overlap of values between patients with different 
cardiac diseases, between patients and normal subjects, and the 
wide variations of values within each cardiac disease render any 
attempt at establishing reference values fruitless. However, 
patients with various clinical symptoms, with and without 
arrhythmias, and on various medications have been included in 
these pooled studies, which probably accounts for part of the 
variation. 
 Generally, QTc dispersion is increased in acute MI, although 
mean values form 40 ±b 18 to 162.3 ± 64.8 ms have been reported 
(75, 83). Although QTc dispersion is increased in the chronic phase 
of MI and in other chronic forms of ischemic artery disease, there 
seems to be a trend towards lower values compared with the acute 
phase of MI, possibly due to the spontaneous dynamicity or to 
revascularization procedures. Some authors did not find significant 
differences in QT dispersion between patients with chronic MI or 
other forms of chronic CAD and normal subject (84, 85). 
 Compared with healthy controls, an increased QTc dispersion 
has been reported in heart failure and left ventricular dysfunction 
of various origin (93, 94, 95, 96 and 97), in patients with arterial 
hypertension irrespective of the presence or absence of hypertrophy 
(98), in HCM patients compared with healthy controls (99, 100 and 
101), in long  QT syndrome (102, 103 and 104) and in many other 
cardiac and even noncardiac disease. However, some studies have 
found QTc dispersion values not significantly different between 
healthy subjects and patients with heart failure (105), patients 
with LVH as result of physical training (106, 107 and 108), or 
between patients with and without LVH (109). 
 Many studies tried to correlate QTc dispersion with the 
extent or the localization of the pathological process of various 
diseases. Some studies have shown greater QTc dispersion in 
anterior compared to inferior MI (110, 111 and 112); correlation 
between QTc dispersion in MI and indirect measures of infarct size, 
such as ejection fraction (113); or the amount of viable myocardium 
in the infarct region (114). Similarly, significant correlation 
between QTc dispersion an left ventricular mass index in 
hypertensive patients with LVH was found in some studies (115, 
116), but not in other (117). 
 Changes of QTc dispersion have been shown to follow the 
spontaneous or induced dynamicity of the pathological process in 
some cardiac diseases. For instance, QTc dispersion seems to 
undergo dynamic changes during the first day (118), as well as 
during the following days (119, 120), of acute MI. It increases 
significantly during ischemia induced by balloon inflation during 
angioplasty (121, 122 and 123), by exercise stress testing (124) or 
atrial pacing (125), or during reperfusion following angioplasty 
(126). It has also been shown to correlate with improvement of left 
ventricular contractility on the echocardiogram after infarction 
(127) and with the degree of improvement of left ventricular 
function after revascularization (128 and 129). 
 Treatment has been shown to decrease QTc dispersion, e.g., 
after successful reperfusion after thrombolysis (130 and 131), 
revascularization with angioplasty (132, 133 and 134) or coronary 
artery bypass grafting (129). Treatment of patients with heart 
failure with losartan (135), successful antihypertensive treatment 
of patients who had hypertension with LVH (136, 137, 138 and 139), 
or successful beta-blocker treatment of patients with long-QT 
syndrome (140) have also been shown to decrease QTc dispersion. 
Prognostic value of QTc dispersion 
 Many studies have been aimed at investigating the value of 
QTc dispersion for the prediction of ventricular arrhythmias or 
other adverse events in various cardiac diseases. The results are 
again controversial. 
 Data from 23 studies on  patients with and without serious 
ventricular arryhthmias in various cardiac diseases, most of them 
with ischemic heart disease. Altogether, 490 patients with and 
1,341 patients without serious ventricular arrhythmias were 
included. Although most studies show significantly greater QTc 
dispersion in patients with arrhythmias, the values largely overlap. 
 Several studies, most of them retrospective, have found that 
patients with acute (141 and 142) or chronic MI (143, 144 and 145) 
with ventricular arrhythmias have significantly higher QTc 
dispersion than patients without arrhythmias. However, the first 
prospectively analysed study in post-MI patient reported by Zabel 
et al. (146) showed that none of the 26 ventricular dispersion 
indices that were tested had any predictive value for an adverse 
outcome in 280 consecutive MI survivors followed up for 31 ± 10 
months. Newer studies (147, 148) provided controversial findings. 
 Some studies showed that QTc dispersion could predict 
inducibility of ventricular arrythmias during electrophysiology 
study (149, 150 and 151), whereas other failed to observe this (152, 
153 and 154). 
 Several studies (155, 156 and 157) showed significant 
correlation between QTc dispersion and outcome in patients with 
heart failure. Analysis (158) from the ELITE heart failure study, in 
which heart failure patients treated with the angiotensin-II 
antagonist losartan had reduction of sudden cardiac death 
compared with those treated with captopril (159), showed that 
captopril but not losartan increased QTc dispersion. However, the 
results of ELITE were not confirmed by the much larger double-
blind. Randomized controlled ELITE-II trail (160), in which 
patients treated with losartan showed no significant differences in 
all-cause mortality, sudden death or resuscitated cardiac arrest 
compared with those treated with captopril. 
 Substudies of the DAMOND-CHF Study (161), the UK-
HEART study (162) as well as other large prospective studies (163) 
failed to show any power of QTc dispersion for predicting outcome 
in heart failure patients. Available studies also failed to show 
independent predictive value of QTc dispersion for sudden cardiac 
death and cardiac mortality in patients with LVH (164). 
 Several authors reported significantly higher QTc dispersion 
in HCM patients with ventricular arrhythmias compared with 
those without arrhythmias (165, 166 and 167). Larger studies, 
however, did not confirm these findings (168 and 169). 
 In long-QT syndrome, the diagnostic value of increased QTc 
dispersion seems undisputed. On the other hand, although Prior et 
al. (170) reported that patients not responding to beta-blockers had 
a significantly higher QTc dispersion than responders (137 ± 52 vs. 
75 ± 38 ms, p <0.05), no other presently available data suggest that 
QTc dispersion has any prognostic value in patient with long QT 
syndrome. 
 Generally, the positive results of small retrospective studies 
conducted in the years of initial enthusiasm were later confirmed 
only by some very large prospective studies. However, even in the 
large studies,  patient groups with adverse outcomes often had QTc 
dispersion values well within both the measurement error and the 
range of values in healthy subjects reported in other studies. Thus, 
as phrased by Surawicz (171), the positive results can be 
interpreted as indicating an “indifferent” QTc dispersion. This does 
not necessarily signify lack of clinical importance. In the majority of 
the cases, the abnormality was already visible from abnormal T 
wave morphology and increased QTc interval. At present, this does 
not necessitate a specific therapeutic action and, in practice, does 
not help in the risk stratification of individual patients. 
Effect of drugs on QTc dispersion and the risk of torsades 
de pointes tachycardia 
 The limitations of both the presence and the degree of QTc 
interval prolongation for prediction of torsades de pointes are well 
known (172). Consequently, the potential role of QTc dispersion for 
the prediction of drug-induced torsade de pointes has been 
addressed in several studies. 
 Quinidine increase QTc dispersion (173 and 174) and, unlike 
the corrected QTc interval, increased QTc dispersion seems to have 
some predictive value for development of torsades de pointes during 
quinindine therapy (173 and 174). Sotalol has been shown to 
decrease (175) or not to change (176) QTc dispersion in patients 
with ischemic heart disease. However, Dancye et al. (177) observed 
increased QTc dispersion in 4 cases of torsades de pointes caused 
by low dose sotalol in patients with renal failure. 
 In clinical studies, amiodarone has been reported to decrease 
(176 and 178) or not to change (173, 179 and 180) QTc dispersion. It 
is known that amiodarone can be administered relatively safely in 
patients who had experienced torsades de pointes during 
antiarrhythmic therapy with other drugs (181) and this effect is 
paralleled by a decrease of QTc dispersion (173). However, cases of 
an excessive increase of QTc dispersion and induction of torsades 
de pointes by amiodarone have also been reported (1820). On the 
other hand, it has been demonstrated that increase of QTc mean 
and QTc dispersion during chronic amiodarone treatment does not 
affect survival and is independent of the decrease in arrhythmia 
risk (183). 
 Propafenone (184), disopyramide (185) and almokalant 
(blocker of the rapid component of the delayed rectifier, I Kr) (186) 
has been shown to increase QTc dispersion, whereas in one study 
dofetilide infusion did not produce increase of the dispersion of 
repolarization between two right ventricular endocardial sites (187). 
A decrease of QTc dispersion after treatment with aximilide (188) 
and magnesium has also been reported (189). 
 In addition to long  QT syndrome (140) beta-blockers have 
been shown to decrease QTc dispersion in patients with syndrome 
X (190) and heart failure (191), but not in HCM (168). 
 Grossly abnormal values (e.g., ≥ 100 ms, unlikely to be due to 
measurement error) during treatment with drugs affecting 
repolarization signify “bad QTc dispersion” (171), which probably 
should prompt urgent assessment of the drug effect. 
Indian perspective  
 With regard to the Indian perspective very few studies (200, 
201) have been cited in literature. A study in India showed that 
means QTc dispersion in normal individual as 51.45 ± 5.56 msec 
(193). In a study by Parale et al. 100 patients with AMI were 
compared to controls. It was found that QTc dispersion was higher 
in patients with AMI compared to controls (109.11 ± 25.77 msec vs 
51.45 ± 5.50 msec). QTc dispersion was found to be prolonged in 
patients who developed ventricular arrhythmias as compared to 


















and Methods   
MATERIALS AND METHODS 
Study Population and Design 
The design was a cross sectional study comprising of 100 
patients admitted with acute myocardial infarction to the Intensive 
Care Unit of Government Royapettah Hospital, Kilpauk Medical 
College during the period from  January 2006 to July 2006. A 
control of 50 patients who were not diseased were screened and 
selected randomly from the outpatient department. 
Inclusion Criteria 
Patients with acute myocardial infarction with ST elevation 
getting admitted to Intensive Coronary Care Unit who were 
thrombolysed were included. The drug used for thrombolysis was 
streptokinase. 
Exclusion Criteria 
 Patients with Non ST elevation myocardial infarction were 
excluded . 
 Patients  with previous history of myocardial infarction.  
 Patients with complete heart block. 
 Patients  with atrial fibrillation. 
 Patients  with history of intake of drugs prolonging QTc 
dispersion such as quinine, disopyramide, procainamide, 
tricyclic anti depressants and  phenothiazines. 
Selection of Controls 
50 patients who had no history of any medical disease in  the 
past were randomly selected from  outpatient department after 
proper screening. 
Data Collection and Assessment 
Detailed questionnaire regarding history, examination 
findings were filled up for each patient. Assessment included 
baseline investigations, ECG and presence  of any of the 
complications such as left ventricular failure, arrythmias and death. 
History included enquiries regarding the time of onset of 
chest pain, dyspnoea, syncope, diabetes, hypertension, coronary 
heart disease and smoking . 
Complete physical examination with specific note in arterial 
pulse, blood pressure, jugular venous pulse, auscultation of 
cardiovascular system and respiratory system were done at the 
time of admission, post thrombolysis and at the end of day one. 
ECGs were taken at the time of admission, post thrombolysis and 
after twenty four hours using HP page writer, besides this all 
patients had continuous ECG monitoring. 
Heart rate, corrected QTc interval, shortest QTc, longest QTc 
and QTc dispersion were found out from twelve lead ECG at 
25mmper second speed. Occurrence  of arrhythmias, left 
ventricular failure, death, post infarction angina were noted. The 
treatment regimens given, with special emphasis to usage of beta 
blockers and angiotensin converting enzyme inhibitors were also 
noted. 
Corrected QTc was found out by application of modified 
Bazetts formula, QTc = QT in seconds/square root of RR interval in 
seconds. QTc is measured from the beginning of Q wave or R wave 
if Q is absent to the point at which descending limb of T joins the 
baseline. QTc was measured in all leads where T wave could be   
identified. QTc mean was calculated from QTc intervals of all the 
leads. QTc dispersion was calculated by the formula QTc maximum 
minus QTc minimum. In this way QTc dispersion was found out at 
the time of admission, post thrombolysis and twenty four hours 
later. 
Statistical Methods 
Comparisons were made between different groups such as 
diabetics and non diabetics, hypertensives and non hypertensives, 
smokers and non smokers, ischemic heart disease and no heart 
disease, AWMI and IWMI, patients in failure and not, dead and 
alive, those on beta blockers or ACE inhibitors.Mean QTc and QTc 
dispersion at admission, post thrombolysis and at 24 hours were 
calculated. Comparisons were  made using student t test at three 
intervals separately. Later the probability of significance was 
calculated based on the former. Values are expressed as mean ± 
standard deviation. Calculation was done using SPSS software 
with the help of our college statistician and researcher working for 
Indian Council For Medical Research. Using SPSS standard 




















DISTRIBUTION ACCORDING TO AGE  
 
Age Number  Percentage  
< 30 1 1 
30-39 9 9 
40-49 22 22 
50-59 26 26 
60-69 28 28 
70-79 10 10 
>80 4 4 
 
 
It is seen that most of the patients belonged to 50-69 yrs 





DISTRIBUTION ACCORDING TO GENDER  
 
Sex Number  Percentage  
Male  82 82 
Female  18 18 
Total  100 100 
 









<30 30- 39 40- 49 50- 59 60- 69 70- 79 >80
Age











DISTRIBUTION ACCORDING TO TYPE OF MI 
 
Type MI Number Percentage 
Anterior wall (AW) 61 61 
Inferior wall (IW) 27 27 






Total 100 100 
 




















 Total 61 cases of anterior wall MI and 39 cases of inferior 
wall MI were taken. Of the 39 patients with IWMI, 12 had 
associated right ventricular MI. 
 
TABLE – 4 
DISTRIBUTION ACCORDING TO HISTORY OF TYPE 2 
DIABETES MELLITUS  
 
History of DM Number  Percentage  
Diabetics  23 23 
Non diabetics 77 77 
Total  100 100 
 









Number  Percentage  
With history of SHTN 46 46 
Without history of SHTN 54 54 
Total  100 100 
 
Of the 100 patients 46 were known hypertensives. 
TABLE -6 
HISTORY OF CORONARY ARTERY DISEASE (CAD) 
 
History Number  Percentage  
CAD 28 28 
No CAD 72 72 
Total  100 100 
 
 28 patients had preexisting coronary artery disease, either 
unstable angina or chronic stable angina. Patients with pre 




 HISTORY OF SMOKING  
 
History Number  Percentage  
Smoking  66 66 
No smoking  34 34 
Total  100 100 
 
 Majority of the patient were smokers 66%. None of the 





 Number  Percentage  
Beta blockers  65 65 
No Beta blockers  35 35 
Total  100 100 
 
 Of the 100 patients, 65 received beta blockers meanwhile 
remaining 35 had some contraindication for Beta-blockers. 
 
 
TABLE - 9 
ACE INHIBITORS  
 
 Number  Percentage  
ACE inhibitors  79 79 
No ACE inhibitors  21 21 
Total 100 100 
 
 There were 21 patients who did not receive ACE inhibitors, 
remaining 79 patients received it. 
TABLE -10 
ARRHYTHMIAS  




No Arrhythmias  91 91 
Total 100 100 
 
 Of the 100 patients, 9 developed ventricular arrhythmias.  
Out of the 9, 7 developed ventricular tachycardia and two 
developed ventricular fibrillation.  
 
 
TYPE OF MI IN PATIENTS WITH ARRHYTHMIAS 
  No  of 
Patients 
Arrhythmias Total 
Male 77 5 82  
SEX Females 14 4 18 
Non AWMI 36 3 39 
AWMI 
AWMI 55 6 61 
Non IWMI 55 6 61  
IWMI IWMI 36 3 39 
RVMI 12 0 12  
RVMI Non RVMI 79 9 88 
 
Arrhythmias were more in males. 
More among anterior wall MI patients. 
Three patients with IWMI developed arrhythmias.  
None among RVMI developed arrhythmias. 
 
TABLE -11 
CASE SUMMARIES  
 
 
 Mean QTc 
dispersion 
SD 
Age  55.34 12.733 
QTc Admission dispersion  
(12 lead ) 
61.59 42.578906 
QTc post SK dispersion  
(12 lead) 
65.81 35.59459 
QTc at 24 hrs dispersion  55.17708 32.82521 
QTc mean admission  422.79 40.20611 
 
 
 Mean age of the patients was 55 years. Mean QTc dispersion 
is given in the table. But standard deviation shows that the range 
was more at the time of admission and reduced on thrombolysis 





12 LEAD QTc DISPERSION IN DIABETICS AND  











Diabetic 420.013 39.7351  
Mean No diabetes 432.0869 41.2640 
 
0.207932 
Diabetes 46.69565 33.58224 Admission 
No diabetes 66.03890 44.13479 
 
0.055465 
Diabetes 62.5456 25.25815 Post SK 
No diabetes 66.78378 38.22438 
 
0.626421 
Diabetes 49.40909 29.81476 24 hrs  




















Admission Post SK 24 hrs 





 Comparison between diabetics and non diabetics was 
showing no significantly prolonged QTc dispersion in diabetics 
(p>0.05). Infact the study show slight reduction in QTc dispersion 
in diabetics. 
TABLE – 13 
QTc DISPERSION IN PATIENTS WITH AND WITHOUT 
SYSTEMIC HYPERTENSION  
 








Hypertension  424.9348 45.84098  
QTc Mean 
No hypertension 420.963 35.04227 
0.624907 
Hypertension  59.30435 43.96507 Admission 
No hypertension 63.53704 41.87471 
 
0.62272 
Hypertension  62.15909 33.70387 Post  SK 
No hypertension 70.59615 36.76116 
0.153319 
Hypertension  55.79454 31.80652 24 hrs  




 There was no statistically significant difference in QTc 
dispersion in patient with and without systemic hypertension. 
Though QTc mean was found be higher among hypertensives,  QTc 
dispersion was lower in hypertensives than non hypertensives. 
 
TABLE -14 
TYPE OF MI AND QTc MEAN DISTRIBUTION  
 Type Mean QTc Standard deviation P value 
Yes (61) 426.4262 42.43994 AWMI 
No (39 417.1026 36.23737 
 
0.260107 
Yes (27) 422.40741 34.16843 IWMI 
No (73) 4229315 42.43895 
 
0.954201 
Yes (12) 405.1667 39.39966 RVMI 




 Though QTc mean was found to be more in AWMI patients it 
was not statistically significant. No such relation could be seen 
with RVMI and IWMI. Though QTc dispersion was higher in IWMI 
compared to RVMI, it is was not statistically significant   
 
TABLE – 15 
QTc DISPERSION  IN AWMI VS IWMI 
 
 Type Mean  QTc dispersion 
Standard 
deviation P value 
AWMI 63 44.6895 Admission  
Non AWMI 59.38462 39.5159 
 
0.680934 
AWMI 70.39655 36.27814 Post SK 
Non AWMI 58.81579 33.79817 
 
0.119563 
AWMI 53.7931 32.53541 24 hrs  




Though QTc were higher in AWMI at admission & post SK 
but there was no statistical significance. 
TABLE -16 
QTc DISPERSION  IN IWMI 
 
  Type  of MI Mean QTc dispersion 
Standard 
deviation P value 
IWMI 69.03704 36.63907 Admission  
Non IWMI 58.8356 44.49126 
0.289758 
IWMI 60.34615 32.07983 Post SK 
Non IWMI 67.84286 36.82494 
0.361875 
IWMI 55.84615 30.51126 24 hrs  
Non IWMI 54.92857 33.51123 
0.903886 
 
Though QTc dispersion was more in IWMI at admission it 




QTc DISPERSION IN RVMI 
 Type Mean QTc dispersion 
Standard 
deviation P value 
RVMI (12) 37.66667 38.44555 Admission  
Non RVMI(88) 64.85227 42.26532 
0.037430 
RVMI (12) 55.5 38.5474 Post SK 
Non RVMI (88) 67.28571 35.15185 
 
0.285669 
RVMI (12) 60.41667 49.78649 24 hrs  




 QTc dispersion was not increased in RVMI was statistically 
significant. This correlated with the least amount of arrhythmias in 
that group. 
TABLE -18 
QTc DISPERSION IN PATIENTS WITH AND WITHOUT LVF 




P value  
LVF (+) (30) 73.666 47.5504 Admission  
LVF (-) (70) 56.41429 39.550.19 
0.063014 
LVF (+ (27) 68.66666 40.16983 Post SK 
LVF (-) (69) 64.69566 33.89053 
0.625636 
LVF (+) (27) 59.44928 39.24015 24 hrs  
LVF (-) (69) 53.44928 30.09668 
0.412560 
 
 QTc dispersion was significantly increased in patient with 
LVF and this was statistically significant especially at admission. 
Since four patients died soon after admission, post SK and 24 hrs 
study had only 96 patients. 
 
TABLE  - 19 
QTc DISPERSION IN SMOKERS AND NON SMOKERS  
 Type Mean  QTc dispersion 
Standard 
deviation P value 
Smoker (66) 65.84849 33.9104 Admission  
Non smoker (34) 53.32353 55.38062 
0.164603 
Smoker (63) 67.90476 34.0084 Post SK 
Non Smoker (33) 61.81818 38.67044 
0.429074 
Smoker (63) 60.68254 34.27207 24 hrs  
Non Smoker (33) 44.66667 27.97662 
0.022365 
 
 QTc dispersion was significantly increased among smokers 
who had  MI and this was statistically significant especially 24 
hours after admission.  
 
TABLE -20 
QTc DISPERSION IN PATIENTS WITH AND WITHOUT CAD  
 CAD Mean  QTc dispersion 
Standard 
deviation P value 
CAD (+) (28) 61.60714 40.21824 Admission  
CAD (-) (72) 61.58333 43.73471 
0.998012 
CAD (+) (25) 53.25926 26.83367 Post SK 
CAD (-) (71) 55.92754 35.04235 
0.844180 
CAD (+) (25) 66.96296 33.6286 24 hrs  
CAD (-) (71) 65.36232 36.56379 
0.722308 
 
 QTc dispersion was slightly increased in  those with CAD 




QTc DISPERSION  IN PATIENTS WITH BETA BLOCKERS 
AND WITHOUT BETA BLOCKERS 
 Beta-Blockers  Mean QTc dispersion  
Standard 
deviation P value 
Yes (65) 61.07692 37.00309 
Admission 
No (35) 62.54286 51.96059 
0.870534 
Yes (64) 66.70313 32.79212 
Post SK 
No (32) 64.03125 41.13901 
0.730794 
Yes (64) 54.45313 26.27506 
24 hrs 
No (32) 56.625 43.53993 
0.761694 
 
 There appeared to be a reduction in QTc dispersion in those 
with Beta blockers especially at admission and at 24 hours, but it 
was not statistically significant. 
TABLE -22 
QTc DISPERSION IN PATIENTS ON ACE INHIBITORS AND 
NOT ON ACE INHIBITORS  
 
 ACE Inhibitors Mean Standard deviation P value 
Yes (29) 58.96202 38.22049 
Admission 
No (71) 71.47619 56.096 
0.233118 
Yes (77) 67.44156 35.34436 
Post SK 
No (19) 59.21053 36.80969 
0.369447 
Yes (77) 55.71429 31.17 
24 hrs 
No (19) 53.3514 39.7316 
0.748716 
 
 Though there was a decrease in QTc dispersion by ACE 
inhibitors at admission it was not sustained at post SK and at 24 
hours. However none of these were statistically significant.  
 
TABLE -23 
QTc DISPERSION IN PATIENTS WITH  AND WITHOUT 
ARRHYTHMIAS 
 
 Arrhythmias Mean QTc dispersion 
Standard 
deviation P value 
Yes (9)  88.7778 2.1103 
Admission 
No (91) 58.9011 39.623 
0.044049 
Yes (6)  69.5 25.493 
Post SK 
No (90)  65.56667 36.261 
0.7948 
Yes (6)  37.3333 35.2344 
24 hrs 
 No (90)  56.3666 32.5191 
0.170316 
 
 QTc dispersion were increased in those with arrhythmias at 
admission  which was statistically significant. However this was 
not sustained at 24 hrs and post SK. This is because of protective  
effect of streptokinase and  treatment given.  
TABLE - 24 
 MEAN QTc ANALYSIS AT  ADMISSION  
 
Variable  Mean QTc 
dispersion 
S.D. P value 
66 (Y) 419.5909 45.15954 
Smoker 
34 (N) 429 27.79252 
0.269768 
28 (Y) 424.3214 37.66328 
CAD 
72 (N) 422.1945 41.39219 
0.813626 
65 (Y) 422.6769 37.57497 
Beta - blocker 35 (N) 423 45.26848 
0.969659 
79 (Y) 426.0253 40.05284 ACE 
inhibitors 21 (N) 410.219 39.35032 
0.119105 
23 (Y) 420.013 39.7351 
Diabetes 
77 (N) 432.0869 41.2640 
0.207932 
46 (Y) 424.9348 45.84098 
Hypertension 
54 (N) 420.963 35.04227 
0.642903 
9 (Y) 452. 2222 40.03996 
Death 
91 (N) 419.8791 39.24902 
0.020549 
30 (Y) 435.1667 35.48393 
LVF 
70 (N) 417.4857 41.17081 
0.043289 
 
There appears to be no statistically significant effects on QTc mean 
by diabetes, Hypertension, Smoking, CAD, Beta-blockers and ACE 
inhibitors. However there was statistically significant correlation 
between death, LVF and QTc mean. 
TABLE – 25 
QTc DISPERSION IN PATIENTS WHO DIED 
 Alive VS Dead Mean  QTc dispersion 
Standard 
deviation P value 
Dead (9) 85.6666 66.59955 Admission  
Alive (91) 59.2879 39.19453 
0.075212 
Dead (9) 55.2 33.80282 Post SK 
Alive (91) 66.39561 35.80282 
0.496396 
Dead (9) 49.6 23.6072 24 hrs  
Alive (91) 55.48352 33.32812 
0.698552 
 
 QTc dispersion was significantly increased in those who died 
especially soon after admission. However this effect was not 
sustained and there was no statistical significance to any of the 
remaining data analysed.  The protective role of thrombolysis could 
been seen by the reduction of QTc dispersion at post thrombolysis 




ANALYSIS OF CONTROLS 
 
Distribution of Age 
 
Sex Mean Standard Deviation 
Males 49.9166 15.12536 
Females 52.76923 13.61266 
 
Distribution of Mean 
 
Sex Mean QTc Standard Deviation P Value 
Males 380.1667 78.47828 




Distribution of QTc dispersion 
 
Sex Mean QTc dispersion 
Standard 
Deviation P Value 
Males 47.58333 18378 















































 Discussion   
DISCUSSION 
In the present study, 100 patients with acute myocardial 
infarction were considered for QTc dispersion evaluation . This 
included 61 patients with AWMI, 27 patients with IWMI and 12 
patients with RVMI. A control group of 50 asymptomatic patients 
were also included. 
Of the 100 patients, most of patients  ie ,54 belonged to 50-69 
years age group (26 patients in 50 – 59 yrs and 28 patients in 60-69 
yrs). Mean age was 55.34. In other trials such as by Zabel et al  
(198) it was 57 yrs. Average age in Indian study by Yadav et al (200) 
was 51.2 yrs and Reddy et al (201) was 50.37 yrs. One patient was 
less than 30 yrs and was a heavy smoker. However Macfarlane et 
al (11) found no significant age difference in QTc dispersion. 
Majority of the studies in acute myocardial infarction  showed 
male preponderance. In our study also males dominated (82%). Out 
of 18 females only two (12%) were less than 50 yrs, remaining 16 
(88%) were more than 50 yrs. This reiterates the protective role of 
Oestrogen on coronary vessels in premenopausal age. This ratio 
was comparable in other trials also (Zabel et al (198) 82% vs 18% 
and Yadav et al (200) 84% vs 16% and Reddy et al (201) 85% vs 
15%. The ratio was little more in Japanese study of Endoh Y et al 
(197) 75% vs 25%). 
31% of the IWMI were having RVMI. This emphasizes the 
need for taking right ventricular leads routinely in all patients   
apart from standard 12 lead ECG  presenting with AMI. According 
to Reddy et al  he had 54% patients with RVMI and IWMI 
combined. 
 The study also raises concern regarding increasing burden of 
diabetes in Indian population (23%). This may be due to 
Berkisonian bias. This is more than the prevalence in other Indian 
and Western studies (12% Reddy et al (201), Yadav et al (200), 13.7 
Hopkin e al (202)). A comparison between mean QTc in Diabetics 
(420.013 ± 39.73) and non diabetics (432.08 ± 41.23) (p = 0.2079) 
showed no statistical significance. There was no significant relation 
of QTc dispersion  between diabetics  and non diabetics. 
66% of patient were smokers. This is more than other studies 
such as Reddy et al (201) (52%), Yadav et al (200) (58%) and 
Hopkins et al (202) (55%). This may be due to other enviromental 
factors like lifestyle changes and sedentary habits. Hence this is a 
potential reversible factor and  there is plenty of scope for health 
education as preventive measure. 
Systemic hypertension was present in 46% of the study 
subjects. This is accordance with Hopkins et al (202) (46%), 
however much more than the  Indian studies by Reddy et al (201) 
(24%) and Yadav et al (200) (22%). This high incidence may be due 
to life style changes like smoking   and once again  there is scope 
for health education and potential reversibility. 
Comparison between AWMI and IWMI showed that QTc 
dispersion is increased in both [63 m sec and 69 m sec (admission) : 
70m sec and 60 m sec (streptokinase) : 53 m sec and 55 m sec (at 
24hrs)] and was not statistically significant (p >0.05). This is not 
consistent with Morena et al who showed significant increase in 
QTc dispersion  after AWMI vs IWMI. However there was a 
statistically significant relation of QTc dispersion  in those with 
RVMI (p = 0.0374). This observation  perhaps has implication to 
keep those patients with RVMI under strict  monitoring. 
Significant reduction in QTc dispersion  after thrombolysis 
(69 m sec vs 60 m sec) were seen in those with IWMI which was in 
accordance with (193) Parale et al (109.11 vs 87.59) and (203) 
Karagonius et al (75 m sec vs 53m sec). This  emphasize the 
beneficial effect of thrombolysis. However in this study no 
significant reduction was observed in those with  AWMI and RVMI. 
QTc dispersion after AMI (AWMI 63 m sec, IWMI 69 m sec) 
were in  accordance with western studies (Karagonius et al 74 m 
sec ± 38, (199) Hugham P.D. et al – 75 m sec). This observation 
suggest that genetic and ethnic factors may play a role in QTc 
dispersion . Further studies are warranted in this respect. 
QTc dispersion were increased in those with left ventricular 
dysfunction compared with those not in failure (admission 73 vs 56 ; 
post SK 68 vs 64 ; at 24 hrs 59 vs 53 m sec) but none of these were 
statistically significant. This is in accordance to Karagonius et al  
(75 m sec vs 53m sec). Further large  scale studies are warranted 
regarding this aspect (86, 87, 88, 89). 
Patients with CAD showed a slight increase in QTc 
dispersion ,  however it was not statistically significant. This was in 
accordance with Ashihaga et al (84) and Sporton et al (85). 
Patients treated with beta blockers  showed a reduction in 
QTc dispersion  especially at admission (61 vs 62 m sec) , at 24 hrs 
(54vs 56m sec)  and it was not  statistically significant. However 
this is in accordance with Leonardo et al (190) who found out that 
beta blockers will decrease QTc dispersion . The smaller reduction 
in our study may be due to a smaller sample size. However ACE 
inhibitors showed a reduction in QTc dispersion  at admission 
which was not sustained during post SK and  at 24 hrs. None of 
these were statistically significant. 
Most importantly QTc dispersion were significantly increased 
in those with ventricular arrhythmias compared to non arrhythmic 
group (88 vs 58 m sec  at admission ; 69 vs 65 m sec post SK). This 
was statistically significant (p = 0.04). The comparative reduction 
in QTc dispersion  in post SK and 24 hours may be due to a 
conglomerulation of protective effects by thrombolysis and other  
drugs such as ACE inhibitors . This is in accordance with studies of 
(196) Zaputovic et al (77 ± 23 vs 53 ± 27m p<0.01). In study by (199) 
Hugham PD et al it was 105m sec vs 75 m sec at admission. Study 
by Parale et al showed significant difference in QTc dispersion  (148 
± 32.36 vs 105.85 ± 20.24 m sec). This reiterates the role of QTc 
dispersion in predicting arrhythmias. This can be useful for risk 
stratification. 
QTc dispersion was significantly increased in patients who 
died especially at the time of admission (85 vs 59 m sec, p = 0.075) 
but was not statistically significant. 
Analyzing the QTc dispersion in normal control population 
showed 47.5833 ± 18.73 m sec in males and 53.5 ± 17.52 m sec in 
females which is in accordance with Kairtzner et al (70) and Staller 
et al (71) who  reported normal values are between 30 and 70 m sec. 
The mean age of control group was  49.9 ± 15.1 years in males and 
52.7 ± 13.6 years in females. 
Analyzing the QTc mean showed no statistical correlation  in 
patients with  history of smoking, CAD, those being treated with  
beta blockers and ACE inhibitors. However mean QTc were 
prolonged in those who had left ventricular failure (435 ± 35 vs 417 
± 41 m sec) and those who died (452 ±40 vs 419 ± 39 m sec), both  







































 Conclusion   
CONCLUSION 
 QTc dispersion was more and statistically significant in those 
with left ventricular failure at admission. 
 QTc dispersion was more and statistically significant in 
smokers after the first day of infarct. 
 QTc dispersion was more and statistically significant in those 
with ventricular arrhythmia at the time of admission. 
 QTc dispersion was more but not statistically significant in 
those who died. 
 There was positive correlation between usage of ACE 
inhibitors and QTc dispersion reduction at the time of 
admission which was not to be seen in post SK and at 24 hrs. 
 There appeared to be a reduction in QTc dispersion in those 
with Beta-blockers especially at admission and at 24 hours, 
but it was not statistically significant. 
 QTc dispersion was slightly increased in those with CAD 
especially at admission and at 24 hrs but not statistically 
significant. 
 Comparison between diabetics and non diabetics  showed  no 
significant QTc dispersion in diabetics (P>0.05). Infact the 
study show slight reduction in QTc dispersion in diabetics. 
 There was no statistically significant difference in QTc 
dispersion in patients with and without systemic 
hypertension. Though QTc mean was found be higher among 
hypertensives , QTc dispersion  was lower in hypertensives 
than non hypertensives. 
 Though QTc mean was found to be more in AWMI patients it 
was not statistically significant. No such relation could be 
seen with RVMI and IWMI. Though QTc dispersion was 
higher in IWMI compared to RVMI, it is was not statistically 
significant   
 The normal QTc dispersion among  healthy  Indian 
individuals corresponds to those of western data. 
 Though QTc dispersion was higher in AWMI at admission & 
post SK there was no statistical significance. 
 QTc dispersion was increased in those with arrhythmias at 
admission which was statistically significant. However this 
was not sustained at 24 hrs and post SK. This could be 
because of protective effect of streptokinase and  treatment 
given.  
 QTc dispersion were significant increased in those dead 
especially at the time of admission. However this effect was 
not sustained and there was no statistical significance to any 
other data analysed.  The protective role of thrombolysis 
could be seen by the reduction of QTc dispersion at post 
thrombolysis and at 24 hrs. 
 There was statistically significant correlation between left 
ventricular failure and QTc mean. 
 The role of QTc dispersion in the present scenario should be 
questioned as most of the parameters correlated negatively 





































 Summary  
SUMMARY 
QTc dispersion was more and statistically significant in those 
with left ventricular failure at admission. QTc dispersion was more 
and statistically significant in smokers after the first day of infarct. 
QTc dispersion was more and statistically significant in those with 
ventricular arrhythmia at the time of admission. QTc dispersion 
was more but not statistically significant in those who died. There 
was positive correlation with usage of ACE inhibitors and QTc 
dispersion  reduction at the time of admission which was not to be 
seen in post SK and at 24 hrs. There was no significant correlation 
between beta blockers and QTc dispersion. There was no significant 
correlation between CAD patients and QTc dispersion. There was 
no significant correlation between diabetes and QTc dispersion. 
There was no significant correlation between hypertension and QTc 
dispersion. There was no significant correlation between the type of 
infract and QTc dispersion. The normal QTc dispersion among 
normal Indian individuals corresponds to those of western data. 
There was no statistically significant difference in QTc mean and 
various types of myocardial infarction. There was a statistically 
significant positive correlation between incidence of arrhythmia 
and QTc mean. There was statistically significant positive 
correlation between death and QTc mean. There was statistically 
significant correlation between left ventricular failure and QTc 
mean. 
 Contrary to the initial expectations, QTc dispersion did not 
evolve into a useful clinical tool. Although this simple ECG 
parameter is probably not (only) a result of measurement error, it 
does not reflect directly and in quantifiable way the dispersion and 
the heterogeneity of the ventricular recovery times. The standard 
12-lead ECG contains information about regional electrical 
phenomena, but this information cannot be extracted by such a 
simple technique as QTc dispersion assessment. 
 In addition, not only the magnitude of dispersion of recovery 
times, but the distance over which they are dispersed is important 
for arrhythmogenesis. In a similar way as we distinguish, though 
arbitrarily, “micro reentry” from “macro reentry,” it seems logical to 
distinguish dispersion of recovery times of adjacent areas (global 
dispersion) and possible, from dispersion between both ventricles 
(interventricular dispersion). Such a scale is clearly beyond the 
resolution of the standard surface ECG. Local dispersion of 
recovery times created by MI is no more visible on the standard 
surface ECG than the delayed conduction caused by the same 
infarct. 
 The very idea of detecting and quantifying only the 
dispersion of the end of repolarization, i.e., the dispersion of the 
complete recovery times, also seems questionable. Action potentials 
of different duration usually have very different shape, particularly 
during phase 3. Such a “phase 3 dispersion,” i.e., the dispersion of 
the partial recovery times, has direct relation to arrhythmogenesis. 
Although it is reflected in the shape of the T wave, it does not 
contribute to the dispersion of the ends of the MAPs, let alone the 
dispersion of the QTc  intervals. 
 In a recently published experimental study Shimizu et al. 
(192) showed that the T wave alternans induced by rapid pacing 
were a result of alterations in the APD of the M-cells, leading to 
exaggeration of transmural dispersion of repolarization during 
alternate beats and thus to the potential for developmental of 
torsades de pointes. The result of the study clearly emphasized that 
spatial dispersion of the recovery times cannot be estimated 
without the analysis of the morphology of the T wave, as well as 
without taking into account its dynamicity. 
Similarly in this study too, the efficacy of QTc dispersion  as 
prognostic indicator does not faithfully impress on itself. This is 
because there was considerable overlap between QTc dispersion  in 
controls and MI patients. Moreover QTc dispersion  was found to be 
significantly increased only in left ventricular failure, 
arrhythmias ,patients who died whereas in other comparisons 
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ABBREVIATIONS 
β (-)  Beta blocker 
ACE (-) Angiotensin converting enzyme inhabitor 
AMI  Acute myocardial infarction 
APD  Action potential duration 
AWMI Anterior wall myocardial infarction 
CAD  Coronary artery diseases 
CI  Confidence interval 
DM  Diabetes mellitus 
ECG  Electrocardiogram 
HCM  Hypertrophic cardiomyopathy 
HP  Hewlett packard 
IWMI Inferior wall myocardial infarction 
LVF  Left ventricular failure  
MAP  Monophasic action potential 
MI  Myocardial infarction 
QTc  QT interval corrected 
QTd  Corrected QT dispersion 
RVMI  Right ventricular myocardial infarction 
SHTN Systemic hypertension  
SK  streptokinase 




Name  :    Age  : 
Sex  : Male / Female Occupation : 
Date of Admission :    IP No. : 
Date of discharge :   Date of MI and index pain : 
 
 
History Yes No Duration 
Chest pain    
Dyspnoea    
Syncope    
Resuscitated Cardiac arrest    
h/o diabetes mellitus    
h/o hypertension    
h/o coronary artery disease    
h/o smoking    
 
 
Examination Pulse BP JVP CVS Chest 
At admission      
24 hrs      
48 hrs      
 
 
Treatment given Yes No 
Beta blockers   
Ace inhibitors   
Aspirin   
Clopidogrel   
Nitrates   
 
 Admission Post SK 24 hrs after 
ECG    
Mean QTc    
Shortest QTc    
Longest QTc    
QTc dispersion 
in 12 led ECG 
   
 
 Yes No 
Arrhythmias   
Post infarction angina   
Reinfarction   
Clinically detected left Ventricular failure   
Death   
 
 
 
 
 
 
